<DOC>
	<DOCNO>NCT01737931</DOCNO>
	<brief_summary>To investigate efficacy symptomatic therapy topical steroid antihistamine application site reaction ( ASR ) administration SPM 962 healthy subject</brief_summary>
	<brief_title>A Trial Explore Symptomatic Therapy Application Site Reaction SPM962 Healthy Subject</brief_title>
	<detailed_description />
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<mesh_term>Histamine H1 Antagonists</mesh_term>
	<mesh_term>Histamine Antagonists</mesh_term>
	<criteria>Subject male female age 20 45 year age ( inclusive ) Subject normal body weight determined bodymass index ( BMI ) 18 28 kg/m2 Subject healthy determine EA ( medical history , physical examination , skin evaluation , vital sign , ECG , hematology , clinical chemistry , urinalysis ) Subject surgically sterile ; subject postmenopausal least 12 consecutive month female ; subject agree remain abstinent follow two acceptable method birth control EA end observation period . ( fore male female subject ) Subject history complication epilepsy and/or seizure Subject clinically relevant change ECG , second thirddegree AV block , complete bundle branch block , prolongation QRS complex 120 m , QTcB ( QT interval correct HR BazettÂ´s formula ) 500 m EA Subject clinically relevant hepatic dysfunction Subject clinically relevant renal dysfunction Subject history significant skin hypersensitivity adhesives transdermal product recent unresolved contact dermatitis Subject history complication atopic eczematous dermatitis , psoriasis , and/or active skin disease skin tumor Subject 1 know suspected drug hypersensitivity , particular component trial medication Subject history chronic alcohol drug abuse within last 5 year Subject test positive HIV1/2Ab , HBsAg HCVAb Subject test positive alcohol and/or drug EA Subject take prohibited concomitant medication Subject history complication narrow angle glaucoma Subject history complication respiratory cardiovascular disorder ( e.g. , heart failure , coronary heart disease , hypertension , arrhythmia , tachyarrhythmia , myocardial infarction ) Subject history complication psychic abnormality , psychiatric neurologic illness , autonomic neuropathy Subject history complication diabetes mellitus and/or thyroid dysfunction , especially hyperthyroidism endocrine disorder Subject history complication malignancy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>SPM 962</keyword>
	<keyword>rotigotine</keyword>
	<keyword>application site reaction</keyword>
</DOC>